CDK6-specific inhibitor PD0332991 in the gastric cancer cell line led to cell cycle arrest in the G1 phase of the cell cycle with inhibition of pRb at ser780 along with induction of p27 and p53, and therefore has been implicated as a potential therapeutic option [120]. This evidence concerns the gene CDK6 and gastric cancer.